Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

NUTRI-NEED

Financiado

Cerrado

Final development clinical validation and launch preparation of NL01 an innova...

Final development clinical validation and launch preparation of NL01 an innovative health ingredient for supplements food products and foods for special medical purposes People want to live a long and healthy life and there is a huge demand for food products to enable this. Among consumers, the most desired health benefits in food products and supplements are ‘supports immune function’ and ‘increa... ver más

31/05/2020

NutriLeads

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

NUTRILEADS BV No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 3 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2020-05-31

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 7 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

3 Participantes

NutriLeads

2.50M€ | Lider

CONSERVAS LAZAYA FRUTAS Y DU...

277.74K€ | Participante

Natra Oñati, S.A.

487.42K€ | Participante

Proyectos interesantes

AGL2015-70708-R

Medical Technol...

Food Safety

85K€ Cerrado

RTI2018-097043-B-I00

Medical Technol...

Food Safety

73K€ Cerrado

AGL2012-40247-C02-01

Medical Technol...

Agriculture and...

88K€ Cerrado

IJC2018-037095-I

Medical Technol...

Food Safety

93K€ Cerrado

JCI-2011-11397

Medical Technol...

Nutrition

96K€ Cerrado

AGL2015-70640-R

Medical Technol...

Food Safety

Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 23 meses Fecha Inicio: 2018-06-29
Fecha Fin: 2020-05-31

Líder del proyecto

NUTRILEADS BV No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto People want to live a long and healthy life and there is a huge demand for food products to enable this. Among consumers, the most desired health benefits in food products and supplements are ‘supports immune function’ and ‘increases resistance to infections’. NutriLeads is a dynamic Health Ingredients company developing crop-derived food ingredients with clinically proven health benefits. With its proprietary lead ingredient NL01, having completed preclinical data and proven safety in humans, NutriLeads is on track to become the first company to launch an ingredient with an approved health claim for supporting immune function and increasing infection resistance. Targeted end-users of NL01 containing food products (dietary supplements, medical- and functional foods) are young adults, adults, elderly and patients, aiming to support their health and immune status. Nutrileads selected a common crop from which NL01 can be isolated, a game-changer for its commercial success,and developed the isolation process for NL01 up to small scale industrial plant production. In this project, Nutrileads will perform medium scale-up of the production process to 250 kg. Nutrileads will complete the data package for NL01 with a clinical study in a relevant population with increased infection risk to support the health claims on NL01, register NL01 as ‘Novel Food’ and obtain European Food Safety Authority (EFSA) regulatory advice on registration as ‘Food for Specific Medical Purposes’. NutriLeads will generate revenues from out-licensing NL01 to large companies in the food industry. Market leaders Abbott, Nestlé, Friesland Campina, Danone, Fresenius regularly in-licence components for inclusion in their products; Nestlé and DSM have already shown interest in Nutrileads’ products. Nutrileads works towards market entry and first deals during or directly after this project with a projected best-case cumulative revenues of €115 million in 2026, representing >46x the EC grant.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores